Our Partners

Investor Relations and News

• MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand December 21, 2020

  CEDAR KNOLLS, N.J., Dec. 21, 2020 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it has entered into an agreement with Science Biotech to exclusively distribute its Fortetropin® products in Australia [...]
  MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders December 15, 2020

  CEDAR KNOLLS, N.J., Dec. 15, 2020 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), is a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health. MYOS is the sole owner of Fortetropin®, a proprietary advanced nutrition product developed and owned by MYOS, that has been shown in [...]
  Learn More ›
• Special Meeting of Shareholders November 16, 2020 • 10:00am ET

  Virtual Meeting

  
  

  Webcast
  MYOS RENS Technology Q1 2020 Results Conference Call May 8, 2020 • 11:30 am ET